Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).GlobeNewsWire • 09/27/19
Xeris Pharma's Gvoke: Strong Approval Chances, But This Is A Highly Competitive SpaceSeeking Alpha • 09/06/19
Xeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/19